Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.055M
March 31, 2026 -9.047M
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 -0.034M
March 31, 2025 -10.81M
December 31, 2024 -0.033M
September 30, 2024 -0.015M
June 30, 2024 -9.65M
March 31, 2024 -5.42M
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 -5.002M
Date Value
March 31, 2023 -0.006M
December 31, 2022 -0.003M
September 30, 2022 -0.004M
June 30, 2022 -0.009M
March 31, 2022 -0.026M
December 31, 2021 -0.025M
September 30, 2021 -17.29M
June 30, 2021 -0.005M
March 31, 2021 -0.034M
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 -0.036M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. -0.492M
Travere Therapeutics, Inc. -30.20M
REGENXBIO, Inc. -19.38M
Krystal Biotech, Inc. -15.16M
ACADIA Pharmaceuticals, Inc. -10.49M